Sibling Group Holdings, Inc. Stock Other OTC
Equities
SIBE
US8257841010
Biotechnology & Medical Research
Financials (USD)
Sales 2014 | 0.15 | Sales 2015 | 2.21 | Capitalization | 12.15M |
---|---|---|---|---|---|
Net income 2014 | -1M | Net income 2015 | -7M | EV / Sales 2014 | 26,727,146 x |
Net Debt 2014 | 110K | Net cash position 2015 | 5.29M | EV / Sales 2015 | 3,109,835 x |
P/E ratio 2014 |
-1.83
x | P/E ratio 2015 |
-0.74
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 94.26% |
Managers | Title | Age | Since |
---|---|---|---|
Jihad Mohammad
CEO | Chief Executive Officer | - | 23-09-19 |
Hussein A. Anani
CEO | Chief Executive Officer | - | 20-12-31 |
Mouktar Makkouk
DFI | Director of Finance/CFO | - | 23-09-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jihad Mohammad
CEO | Chief Executive Officer | - | 23-09-19 |
1st Jan change | Capi. | |
---|---|---|
+23.50% | 45.01B | |
+47.19% | 40.96B | |
-5.16% | 38.62B | |
+36.37% | 32.6B | |
-7.79% | 27.49B | |
+18.06% | 27.17B | |
+47.29% | 14.61B | |
+41.91% | 12.95B | |
-1.02% | 11.36B |